Catalyst Wire Dossier Catalyst Wire Dossier

MVA

Modified Vaccinia Ankara vector encoding malaria antigens ME-TRAP, CS, AMA1 · Bavarian Nordic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MVA, covering 2013-11-11 to 2013-11-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1 [Phase 1, Phase 2]

See pricing